Imugene will forge ahead with a planned pivotal US trial for its blood cancer therapy Azer-cel, having recorded more ‘complete responses’ in its phase 1b study.

How "Our Cow"is changing the way Aussies buy meat 🧑🌾🥩
07:27

Money News with James Willis 💵📊📻 - Tuesday, 17th March
38:41

Economist calls out government spending after rate hike ⬆️💰
09:57